Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Iran mass produces MS drug Ziferon
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
DNA strand breakage by peroxidase-activated mitoxantrone.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Pages
« first
‹ previous
…
49
50
51
52
53
54
55
56
57
…
next ›
last »